Ablynx Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include CytomX Therapeutics.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 1981 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 277161% increase | Employees 15815% increase |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 78 m |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) $76.2m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income ($17.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 132.4m |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company